Latest Legal Activities on Mitsubishi Tanabe's Drug Patents

Given below is the list of recent legal activities going on the following drug patents of Mitsubishi Tanabe.

Activity	Date	Patent Number
Critical Events for all Patents
Patent Issue Date Used in PTA Calculation Critical	23 Aug, 2005	US6933310
Recordation of Patent Grant Mailed Critical	23 Aug, 2005	US6933310
Issue Notification Mailed Critical	03 Aug, 2005	US6933310
Dispatch to FDC	29 Jun, 2005	US6933310
Application Is Considered Ready for Issue Critical	23 Jun, 2005	US6933310
Issue Fee Payment Verified Critical	07 Jun, 2005	US6933310
Issue Fee Payment Received Critical	07 Jun, 2005	US6933310
Mail Notice of Allowance Critical	24 Mar, 2005	US6933310
Notice of Allowance Data Verification Completed Critical	23 Mar, 2005	US6933310
Miscellaneous Incoming Letter	14 Dec, 2004	US6933310
Mail Final Rejection (PTOL - 326) Critical	01 Dec, 2004	US6933310
Final Rejection Critical	29 Nov, 2004	US6933310
Date Forwarded to Examiner	24 Aug, 2004	US6933310
Supplemental Response Critical	17 Aug, 2004	US6933310
Date Forwarded to Examiner	10 Aug, 2004	US6933310

1. Radicava

Radicava is protected by 1 patent, which has expired already. Check out its patent list below.

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Radicava's drug page